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Background
Prophylactic radiation therapy (RT) is an established adjuvant therapy for heterotopic ossification (HO) of the hip when delivered in the immediate pre-or post-operative setting. Its role in prevention of recurrence after excision of HO is supported by randomized trials for HO of the hip, but there is scant evidence to support a similar approach in non-hip joints. In the current study, we evaluate radiologic and functional outcomes after prophylactic radiation therapy (RT) for prevention of HO of the knee and upper extremity [elbow and metacarpophalangeal (MCP) joints].
Methods
With IRB approval, patients treated at our institution with prophylactic RT for non-hip HO from 1998-2009 were identified. Records were reviewed, including pre-and post-operative records, operative reports, and radiography. The primary objectives were to determine the safety and rate of treatment failure, as defined by need, for further surgical intervention.
Results
A total of 30 patients received prophylactic RT for HO of the elbow (n=21), MCP joint (n=1), and knee (n=8). Twenty-nine of the 30 patients were treated within 24-48 hours post-operatively and 1 patient was treated within 24 hours pre-operatively. Based on institutional policy, only patients considered to be at high risk of recurrence were selected to receive prophylactic RT. The median patient age was 47 years (range, 15-78 years). Patients were treated to a dose of 7 Gy in one fraction, with 2 parallel opposed fields (anteriorposterior and posterior-anterior). Median field size was was 9.0 cm wide (range, 7.2-18.1 cm) by 12.0 cm long (range, 9.6-19.7 cm) for the elbow and 13.75 cm wide (range, 8-34.7 cm) by 12.35 cm long (range, 8.5-16.4 cm) for the knee. Complications following treatment included: 2 patients with post-operative wound infections, 1 patient with a ruptured triceps tendon, and 1 patient with a fracture within the treatment field. Follow-up information was available for 26/30 patients, with a median follow-up time of 16 months (range 2-143 months). Recurrent HO, requiring surgical re-excision, developed in 10.5% (n=2) of patients who were followed for upper extremity HO (n=19). For patients followed after RT for HO of the knee (n=7), there were no recurrences of HO that required further intervention.
Conclusion
This represents the largest reported series to evaluate the safety and efficacy of prophylactic RT for prevention of HO for non-hip joints. In this group of patients at high risk for developing further HO, prophylactic RT appears to be a safe adjunct to surgery and is effective in prevention of HO recurrence. Results are similar to published reports of HO of the hip and support the use of surgical excision and perioperative, prophylactic RT for HO of non-hip joints. 
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